MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 104
- 试验地点
- 6
- 主要终点
- Evaluate the sensitivity of MoCA test
研究概览
简要总结
This study concerns elderly patients with cancer with onco-geriatric assessment.
This study propose to associate the collection of the results with the Mini-Cog and the CODEX with the passing of the MoCA and the MMS tests, as well as a neuropsychological assessment, in order to determine if the patients have cognitive impairments, to evaluate the sensitivity of these 4 screening tests in elderly patients seeking treatment for their cancer. The results of this study will make it possible, where appropriate, to adapt the practice in the context of oncogeriatric assessment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 70 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient aged over 70 years
- •Patient with cancer (solid tumor or haemopathy) for whom a first line treatment is envisaged (whatever it is). Surgery and radiotherapy are allowed before entry into the study.
- •Patient candidate for oncogeriatric assessment
- •Patient agree to participate in the study
- •Using the French language
排除标准
- •Primary central nervous system or cerebral metastasis
- •Evolutionary psychiatric pathology known (e.g. schizophrenia)
- •Severe Visual and / or Auditory Impairment
- •Patients unable to respond to cognitive tests
- •Patient (s) deprived of liberty, under guardianship or curatorship
- •Refusal of participation
结局指标
主要结局
Evaluate the sensitivity of MoCA test
时间窗: Up 2 months after inclusion, before initiation of treatment
MoCA is considered clinically relevant if its sensitivity to identify patients with cognitive impairment is at least 75%
次要结局
未报告次要终点